Optimizing combination dabrafenib and trametinib therapy in BRAF mutation-positive advanced melanoma patients: Guidelines from Australian melanoma medical oncologists
Victoria Atkinson, Georgina V Long, Alexander M Menzies, Grant McArthur, Matteo S Carlino, Michael Millward, Rachel Roberts-Thomson, Benjamin Brady, Richard Kefford, Andrew Haydon, Jonathan Cebon
Asia-Pacific Journal of Clinical Oncology | WILEY-BLACKWELL | Published : 2016
We thank Sophie Gibb, PhD CMPP, from WriteSource Medical Pty Ltd who provided medical writing services. Financial support for medical editorial assistance was provided by Novartis Pharmaceuticals Australia.